Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116663703 | 11666370 | 3 | F | 20160630 | 20151027 | 20160705 | EXP | CA-PFIZER INC-2015357741 | PFIZER | 57.00 | YR | F | Y | 0.00000 | 20160705 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116663703 | 11666370 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 10 MG, WEEKLY | 11719 | 10 | MG | TABLET | /wk | ||||||
116663703 | 11666370 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | UNK | 7073 | ||||||||||
116663703 | 11666370 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
116663703 | 11666370 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | UNK | 0 | ||||||||||
116663703 | 11666370 | 5 | SS | REMICADE | INFLIXIMAB | 1 | 3 MG/KG, UNK | 0 | 3 | MG/KG | |||||||||
116663703 | 11666370 | 6 | SS | RITUXAN | RITUXIMAB | 1 | 1000 MG, UNK | 0 | 1000 | MG | |||||||||
116663703 | 11666370 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | 8 MG/KG, UNK | 0 | 8 | MG/KG | |||||||||
116663703 | 11666370 | 8 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116663703 | 11666370 | 1 | Rheumatoid arthritis |
116663703 | 11666370 | 2 | Rheumatoid arthritis |
116663703 | 11666370 | 3 | Rheumatoid arthritis |
116663703 | 11666370 | 4 | Rheumatoid arthritis |
116663703 | 11666370 | 5 | Rheumatoid arthritis |
116663703 | 11666370 | 6 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
116663703 | 11666370 | OT |
116663703 | 11666370 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116663703 | 11666370 | Condition aggravated | |
116663703 | 11666370 | Drug ineffective | |
116663703 | 11666370 | Haematemesis | |
116663703 | 11666370 | Hepatitis | |
116663703 | 11666370 | Hepatotoxicity | |
116663703 | 11666370 | Jaundice | |
116663703 | 11666370 | Nausea | |
116663703 | 11666370 | Rheumatoid arthritis | |
116663703 | 11666370 | Treatment failure | |
116663703 | 11666370 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116663703 | 11666370 | 1 | 20080916 | 20091022 | 0 | |
116663703 | 11666370 | 3 | 20080916 | 20091022 | 0 | |
116663703 | 11666370 | 5 | 20090625 | 20091022 | 0 | |
116663703 | 11666370 | 6 | 2012 | 2015 | 0 | |
116663703 | 11666370 | 7 | 20111026 | 2012 | 0 |